Where to buy sirolimus legally in the US (2026 guide)

Last updated 2026-07-30

Is it actually legal to buy sirolimus without a prescription?

No. Sirolimus is classified by the FDA as a prescription drug, which under federal law means it can't legally be dispensed without a valid prescription from a licensed prescriber. The relevant statute is the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 353(b), which restricts dispensing of certain drugs to prescription only ^[1]. There's no OTC version, no supplement version, and no legal gray zone here the way there is with, say, some peptides sold as "research chemicals." Sirolimus is approved by the FDA as Rapamune (oral solution and tablets) to prevent organ rejection after kidney transplant, and in newer formulations as Fyarro (albumin-bound sirolimus, for a rare soft tissue tumor called malignant perivascular epithelioid cell tumor) and Hyftor (a topical gel for facial angiofibromas in tuberous sclerosis) ^{[2] [3]}. None of the FDA-approved labels mention aging, longevity, or lifespan extension. Any use for that purpose is off-label, meaning a licensed prescriber can legally write for it, but the drug itself was never studied or approved by FDA for that use. Sirolimus and rapamycin are the same molecule. Rapamycin is the generic chemical name (it was originally isolated from soil bacteria on Easter Island, called Rapa Nui, hence the name); sirolimus is the USAN/INN name used on the drug label. You'll see both terms used interchangeably in the longevity world, and in the pharmacy, they are the exact same product. If a website offers to sell you sirolimus without asking for a prescription, that is not a legal US pharmacy. It's either an unlicensed overseas seller, a research-chemical vendor selling an unapproved product not meant for human use, or an outright scam.

What are the actual legal ways to get sirolimus?

There are really only two legitimate paths in the US: a traditional in-person prescription filled at a retail or specialty pharmacy, or a telehealth prescription filled through a licensed pharmacy (often mail-order). Both require a licensed prescriber to evaluate you and write the script; neither can be skipped. Path 1: Your own doctor. Any physician, nurse practitioner, or physician assistant with prescribing authority in your state can write a sirolimus prescription. Most primary care doctors have never prescribed it for longevity and may decline, since it's off-label and carries real immunosuppressive risk. Some are open to it if you bring published data and a clear ask (usually a low, intermittent dose, not the transplant-rejection dosing). Path 2: A longevity-focused telehealth clinic. A growing number of telehealth practices specialize in off-label prescribing for aging-related use, including sirolimus. These typically involve a video or async consult, review of labs (lipid panel, CBC, sometimes HbA1c), and a prescription sent to a partner pharmacy, often a compounding pharmacy that can do non-standard strengths or dosing schedules (like a 6mg weekly dose, which isn't a standard commercial tablet size). Sirolimus Rx is one provider-reviewed route that connects patients to this kind of clinician evaluation and a licensed fulfilling pharmacy; the point of routes like this is that a real clinician reviews your case rather than you self-prescribing off a forum thread. What doesn't count as legal: buying from an overseas online pharmacy shipping into the US without a US-valid prescription, buying "research use only" rapamycin powder from a chemical supplier, or asking a friend with a transplant prescription to share pills. All three are common in longevity forums; none are legal, and the powder route in particular has no quality control at all.

Can I import sirolimus from Canada, India, or Mexico?

Practically, some people do; legally, it's murky and technically against FDA rules for a personal import without an exemption. FDA's Personal Importation Policy is a compliance policy allowing FDA to use enforcement discretion for very limited quantities (generally around a 90-day supply) of a drug for a serious condition when there's no adequate US treatment, but this is discretionary, not a right, and FDA explicitly states it "cannot ensure the safety and effectiveness" of drugs bought from foreign sources ^[4]. Since sirolimus IS available and FDA-approved in the US (as Rapamune, generic sirolimus, Fyarro, Hyftor), the "no adequate treatment available domestically" rationale that sometimes lets personal importation slide doesn't really apply. Importing it specifically to dodge the cost or hassle of a US prescription sits outside what the policy is meant to cover. Generic sirolimus from Indian pharmacies is genuinely cheaper and some longevity users order it that way, accepting the legal ambiguity and the quality-control unknowns (formulation, storage during shipping, counterfeit risk). That's a real choice people make, but it's not "legal" in the clean sense, and if the product is substandard or mislabeled, you have no recourse.

How much does legally prescribed sirolimus actually cost?

Cost varies a lot by source and dose. Generic sirolimus tablets/oral solution, prescribed for its approved transplant indication and filled at a normal retail pharmacy, typically run into the hundreds of dollars per month without insurance, since it's a specialty-tier drug at most insurers. GoodRx and pharmacy pricing data commonly show generic sirolimus 1mg tablets priced well over $200-$400/month cash price depending on pharmacy and dose, though this fluctuates by region and quantity. For off-label longevity dosing, doses are much lower (commonly discussed protocols use something like 3-6mg once weekly, versus daily dosing for transplant patients), so many longevity telehealth programs use compounding pharmacies that price per prescription rather than per standard commercial pack. Reported cash costs for a month's supply of low-dose compounded sirolimus through telehealth programs commonly fall somewhere in the $150-$250 range, though exact pricing depends on the specific clinic, pharmacy, and dose, and neither of us should treat any single number here as fixed since pricing structures change. Insurance essentially never covers off-label longevity use. Insurers pay for FDA-approved indications; since anti-aging isn't one, you should expect to pay cash regardless of which legal route you use.

Do I need labs or a doctor's visit before I can legally get a prescription?

Yes, in any legitimate pathway. A prescriber has a legal and ethical obligation to evaluate a patient before prescribing, and for a drug with real immunosuppressive effects, that generally means at minimum a history, sometimes basic labs like a CBC and lipid panel, and ongoing monitoring. Rapamune's FDA label carries specific warnings, including increased risk of infection, lymphoma and other malignancies, impaired wound healing, and interstitial lung disease, along with effects on lipids (it can raise cholesterol and triglycerides) ^{[3] [3]}. A prescriber worth using will ask about your infection history, current medications (sirolimus has meaningful drug interactions, including with strong CYP3A4 inhibitors and inducers), and won't just rubber-stamp a request. Some telehealth intake forms are lighter than others. If a service will write you a script with zero labs and zero follow-up plan, that's a red flag about the quality of care, even if the transaction itself is technically legal.

What's the actual human evidence for sirolimus and lifespan?

This is the part that gets glossed over by sellers, so it's worth being blunt: there is no completed human randomized trial showing sirolimus/rapamycin extends human lifespan or healthspan. Zero. What exists is strong animal data and a handful of small human safety/biomarker studies. The anchor data point is the NIA's Interventions Testing Program (ITP), a multi-site, NIH-funded program testing candidate longevity compounds in genetically heterogeneous mice across three labs. Rapamycin, tested starting in 2006, has been the single most consistently effective intervention the ITP has found: it extended median lifespan in both sexes across multiple cohorts and multiple starting ages, including when started relatively late in life (600 ppm in food starting at 9 or 20 months) ^{[5] [6]}. That's genuinely a big deal in mouse aging research; it's the single most replicated lifespan-extension result the ITP has produced. In humans, the picture is much thinner. The best-known human sirolimus/aging-adjacent trial is Mannick et al. (2014), which tested an mTOR inhibitor (RAD001, a rapamycin analog, not sirolimus itself) in elderly adults and found improved influenza vaccine response, a biomarker of immune function, not a lifespan or clinical outcome ^[7]. There is no published, completed trial measuring whether low-dose sirolimus extends human lifespan or delays age-related disease onset in otherwise healthy people. The PEARL trial (an open-label, dose-finding study out of AKG's/Novos-affiliated academic collaboration) has looked at safety and some biomarkers of intermittent low-dose sirolimus in healthy adults, but even that is not a lifespan trial and has real limitations in size and design. If you want the fuller picture on what the human evidence does and doesn't show, see sirolimus reviews and is sirolimus worth it, which lay out the gap between the mouse data and what's actually been shown in people.

What are the real risks of off-label, intermittent-dose sirolimus?

The three risks that come up most in off-label longevity dosing are immunosuppression, mouth ulcers, and metabolic changes. None of these are theoretical; they're documented on the drug's own label from decades of transplant use, even though transplant dosing (daily, higher dose, combined with other immunosuppressants) doesn't map perfectly onto weekly low-dose longevity protocols. Immunosuppression is the headline risk, since sirolimus is fundamentally an immunosuppressant; the FDA label for Rapamune warns of increased susceptibility to infection as a class effect of mTOR inhibition ^[3]. Intermittent low-dose users report more colds and slower recovery from minor illness; how much this matters at longevity doses (versus transplant doses) isn't well quantified in humans. Mouth ulcers (stomatitis) are one of the most commonly reported side effects even at low, intermittent doses, showing up in a meaningful share of users in self-reported longevity cohorts and in clinical trial data for mTOR inhibitors generally. They're usually manageable (dose timing, mouthwash protocols) but are the single most common reason people quit their protocol. Metabolic effects cut in an unintuitive direction: sirolimus can raise LDL cholesterol and triglycerides, and in some contexts can worsen insulin resistance, which is awkward given that the whole premise of longevity use is metabolic health. This is exactly why any legitimate prescribing pathway should include baseline and follow-up lipid panels. For a broader rundown on side effects and how people weigh them against the mouse data, sirolimus pros and cons and sirolimus success rate go through the tradeoffs people report in more detail.

How do I tell a legitimate seller from a scam or gray-market source?

A few concrete checks separate a legal, legitimate source from a risky one. None of these require special expertise, just attention. - Does it require a prescription? If a website will sell you sirolimus with no clinician review at all, walk away; that's not legal in the US regardless of what the site claims.

• Is the pharmacy licensed? US pharmacies (including mail-order/compounding pharmacies) are licensed by state boards of pharmacy. You can usually verify a pharmacy's license through the relevant state board of pharmacy website.
• Is the clinician actually licensed to prescribe in your state? Telehealth prescribers must be licensed in the state where the patient is located at the time of the visit, per state medical board rules; a doctor licensed only in another state generally cannot legally prescribe to you across state lines without additional licensure or compact arrangements.
• Does it use the term "research chemical" or "not for human consumption"? That's the standard legal disclaimer used by gray-market powder sellers to avoid FDA drug regulations. Anything labeled this way is not a pharmaceutical product and has no manufacturing quality control comparable to an FDA-regulated drug.
• Is pricing wildly below normal compounding-pharmacy rates? Extremely cheap sirolimus, especially in powder or unusual liquid form, is a signal of an unregulated source, not a bargain. Working through a route where a licensed clinician actually reviews your case, like the provider-reviewed model Sirolimus Rx uses, is the way to keep both the legal and quality-control boxes checked at the same time, since the prescription and the pharmacy fulfillment both stay inside licensed, accountable systems.

Do I need a diagnosis to get a legal sirolimus prescription?

No, not in the sense of needing to have a transplant or the specific FDA-approved conditions. Off-label prescribing is legal in the US; a licensed physician can prescribe an FDA-approved drug for a use outside its approved label based on their clinical judgment, as long as they're not violating other laws (like making false claims to insurers). The FDA itself acknowledges this practice, noting that "off-label" use is common and that the FDA does not regulate the practice of medicine ^[8]. What you do need is a prescriber willing to make that off-label call, which usually means being upfront that you're asking for it for aging/longevity reasons rather than pretending to have a transplant history. Telehealth clinics built around longevity medicine exist specifically because many general practitioners aren't set up for this kind of off-label conversation or don't feel comfortable prescribing an immunosuppressant to a healthy person.

What dose and schedule do legal prescriptions typically use for longevity purposes?

There's no FDA-approved or consensus dose for longevity use, because it's off-label and no completed human lifespan trial exists to establish one. What's commonly prescribed by longevity-focused clinicians, based on extrapolation from mouse data, pharmacokinetic reasoning, and small human biomarker studies, is intermittent low-dose sirolimus, often in the range of roughly 3mg to 6mg taken once weekly, rather than the daily dosing used in transplant medicine. The logic behind weekly rather than daily dosing is pharmacokinetic: sirolimus has a long half-life (approximately 62 hours in the Rapamune label for stable renal transplant patients) ^[3], so infrequent dosing can maintain intermittent mTOR inhibition (the proposed mechanism behind the ITP's lifespan results) while giving the immune system recovery time between doses, in theory reducing continuous immunosuppression. This is a plausible mechanistic argument, not a clinically proven optimal protocol; nobody has run the trial that nails down the best dose or interval in humans for this purpose. For a sense of what people report on typical timelines to notice effects, and what "before and after" actually looks like anecdotally versus in the literature, see sirolimus results timeline and sirolimus before and after.

Frequently asked questions

Can I buy sirolimus over the counter anywhere in the US?

No. Sirolimus is a prescription-only drug in every US state under 21 U.S.C. § 353(b). There's no OTC formulation, no supplement version, and no state where it's sold without a prescription. Any site claiming to sell it OTC in the US is not operating legally.

Is it legal to buy sirolimus from an online pharmacy without a prescription?

No. US law requires a valid prescription from a licensed prescriber before a pharmacy can dispense sirolimus. A website that ships it without asking for one, US or overseas, is not operating as a legal US pharmacy, and you have no consumer protection if something goes wrong.

Is rapamycin the same thing as sirolimus?

Yes. Rapamycin is the generic chemical name for the compound; sirolimus is the official drug name (USAN/INN) used on FDA labeling, sold as brands like Rapamune. They're the identical molecule, and the terms are used interchangeably in longevity contexts.

Does FDA approval mean sirolimus is approved for anti-aging use?

No. FDA has approved sirolimus only for specific indications: preventing organ transplant rejection (Rapamune), a rare soft tissue tumor (Fyarro), and facial angiofibromas from tuberous sclerosis (Hyftor). Any use for aging or lifespan extension is off-label; FDA has never evaluated it for that purpose.

Has any human trial shown sirolimus extends lifespan?

No completed human trial has shown sirolimus extends lifespan. The strongest evidence is in mice, from the NIA Interventions Testing Program, which found rapamycin extended median lifespan across multiple cohorts. Human data is limited to small studies on immune biomarkers and safety, not lifespan or clinical aging outcomes.

Can my regular doctor legally prescribe sirolimus for longevity?

Yes, legally any licensed prescriber can write an off-label prescription for sirolimus if they judge it clinically appropriate. Many primary care doctors decline because they're unfamiliar with the off-label longevity literature or uncomfortable prescribing an immunosuppressant to a healthy patient; that's a clinical choice, not a legal barrier.

Is importing sirolimus from India or Canada legal?

It sits in a gray zone. FDA's personal importation policy allows enforcement discretion for limited quantities of drugs when there's no adequate US treatment, but sirolimus is already FDA-approved and available domestically, so that rationale doesn't clearly apply. FDA states it cannot vouch for the safety of drugs from foreign sources.

How much does a legal sirolimus prescription cost per month?

Retail generic sirolimus for its approved indication commonly runs $200-$400+/month cash price depending on pharmacy and dose. Off-label low-dose compounded sirolimus through longevity telehealth programs is often cheaper, commonly cited in the $150-$250/month range, though pricing varies by clinic and pharmacy.

What labs or monitoring are required before getting a legal prescription?

There's no single legal requirement, but responsible prescribers typically order baseline labs like a CBC and lipid panel before starting sirolimus, given its documented effects on infection risk and cholesterol/triglycerides, and repeat labs periodically during use. A prescriber who skips this isn't practicing careful medicine even if the script itself is technically legal.

What are the main risks of taking sirolimus for longevity off-label?

The three most commonly reported risks are increased infection susceptibility from immunosuppression, mouth ulcers (stomatitis, one of the most common side effects even at low doses), and metabolic changes including raised LDL cholesterol and triglycerides. These are documented in FDA labeling for approved uses; data at low intermittent longevity doses is more limited.

Can a telehealth service legally prescribe sirolimus across state lines?

Only if the prescriber is licensed in the state where the patient is physically located at the time of the visit. State medical boards generally require this. A legitimate telehealth longevity clinic will confirm your state and match you with an appropriately licensed clinician rather than ignoring the requirement.

Do I need a transplant or cancer diagnosis to get a legal sirolimus prescription?

No. Off-label prescribing is legal in the US, and a licensed physician can prescribe sirolimus for reasons outside its FDA-approved indications based on clinical judgment. You don't need to have a transplant or the approved cancer indication; you do need a prescriber willing to make that off-label decision with you.

Sources

1. Cornell Legal Information Institute, 21 U.S.C. § 353: Federal law restricts dispensing of certain drugs, including sirolimus, to prescription only
2. FDA, Fyarro approval information: FDA approved nab-sirolimus (Fyarro) for advanced malignant PEComa
3. FDA, Rapamune (sirolimus) prescribing information: Rapamune label warnings on infection risk, malignancy, half-life (~62 hours), and approved transplant indication
4. FDA, Personal Importation Policy: FDA's compliance policy on personal importation of drugs and its enforcement-discretion, non-guaranteed nature
5. Harrison et al., Nature (2009), NIA Interventions Testing Program: NIA Interventions Testing Program findings that rapamycin extended median lifespan in genetically heterogeneous mice
6. Miller et al., Journals of Gerontology: Biological Sciences (2011): Rapamycin extended lifespan in mice even when treatment started at 20 months of age
7. Mannick et al., Science Translational Medicine (2014): An mTOR inhibitor improved influenza vaccine response (immune biomarker) in elderly adults, not a lifespan outcome
8. FDA, Understanding Unapproved Use of Approved Drugs 'Off Label': FDA acknowledges off-label prescribing is legal and common, and FDA does not regulate the practice of medicine